5,10-Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms: Genotype frequency and association with homocysteine and folate levels in middle-southern Italian adults

Cell Biochemistry and Function

Volumn 32, Issue 1, 2014, Pages 1-4

  Zappacosta, Bruno ^a   Graziano, Mirella ^a   Persichilli, Silvia ^b   Di Castelnuovo, Augusto ^c   Mastroiacovo, Pierpaolo ^d   Iacoviello, Licia ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c IRCCS NEUROMED   (Italy)

^d Alessandra Lisi International Centre on Birth Defects   (Italy)

Author keywords

Folate; Genetic polymorphisms; Homocysteine; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2) GENE; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; ITALY; MALE; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL; WILD TYPE;

FOLATE; GENETIC POLYMORPHISMS; HOMOCYSTEINE; MTHFR;

ADULT; FEMALE; FOLIC ACID; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; ITALY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84891834065     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3019     Document Type: Article

References (29)

1. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567-1577.
2. Wald DS, Kasturiratne A, Simmonds M. Effect of folic acid, with or without other B vitamins, on cognitive disorders: meta-analysis of randomized trials. Am J Med 2010; 123: 522-527.e2.
3. Eussen SJPM, Vollset SE, Ingland J, et al. Plasma folate, related genetic variants and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010; 19: 1328-1340. http://dx.doi.org/10.1158/1055-9965.EPI-09-0841.
4. De-Regil LM, Fernandez-Gaxiola AC, Donswell T, Pena-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010 Oct 6; (10): CD 007950. doi: 10.1002/14651858.CD007950.pub2
5. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995; 274: 1698-1702.
6. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
7. Van der Put NMJ, Gabreels F, Stevens EMB, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051.
8. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172.
9. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detector. J Chromatogr 1987; 422: 43-52.
10. De Stefano V, Zappacosta B, Persichilli S, et al. Prevalence of mild hyperhomocysteinemia and association with thrombophilic genotypes (factor V Leiden and factor II G20210A) in Italian patients with venous thromboembolic disease. Br J Haematol 1999; 106: 564-568.
11. Dhonukshe-Rutten RAM, de Vries JHM, de Bree A, van der Put N, van Staveren WA, de Groot LCPGM. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. Eur J Clin Nutr 2009; 63: 18-30.
12. Zappacosta B, Romano L, Persichilli S, et al. Genotype prevalence and allele frequencies of 5, 10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Italian newborns. LabMedicine 2009; 40: 732-736. doi:10.1309/LMBESO800MMANDOZ.
13. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C>T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7, 000 newborns from 16 areas worldwide. J Med Genet 2003; 40: 619-625.
14. Scala I, Granese B, Sellitto M, et al. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med 2006; 8: 409-416. doi:10.1097/01.gim.0000228206.21793.82.
15. Viel A, Dallagnese L, Simone F, et al. Loss of heterozygosity at the 5, 10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 1997; 75: 1105-1110.
16. Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 2005; 23: 51-54. doi:10.1027/cbf.1132.
17. Friedman G, Goldshmidt N, Friedlander Y, et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999; 129: 1656-1661.
18. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
19. Ma J, Stampfer MJ, Hennekens CH, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410-6.
20. Vohnout B, Arnout J, Krogh V, Donati MB, de Gaetano G, Iacoviello L. European Collaborative Group of the IMMIDIET Project. Association between MTHFR C677T genotype and circulating folate levels irrespective of folate intake: data from the IMMIDIET Project. Nutrition 2011; 2: 1209-10.
21. Dekou V, Whincup P, Papacosta O, et al. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis 2001; 154: 659-66.
22. Friso S, Girelli D, Trabetti E, et al. A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med 2002; 2: 7-12.
23. Ozarda Y, Sucu DK, Hizli B, Aslan D. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Cell Biochem Funct 2009; 27: 568-577. doi:10.1002/cbf.1610.
24. Zappacosta B, Persichilli S, Iacoviello L, et al. Folate, vitamin B12 and homocysteine status in an Italian blood donor population. NMCD 2013; 23: 473-480. doi:10.1016/j.numecd.2011.10.001.
25. Brustolin S, Giugliani R, Felix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res 2010; 43: 1-7.
26. Lievers KJA, Boers GHJ, Verhoef P, et al. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 2001; 79: 522-528. doi:10.1007/s001090100253.
27. Weisberg IL, Jacques PF, Selhub J, et al. The 1298 A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-415.
28. Guéant-Rodriguez RM, Guéant JL, Debard R, et al. Prevalence of methylenetetrahydrofolate reductase C677T and A1298C alleles and folate status: a comparative study in Mexican, West African and European populations. Am J Clin Nutr 2006; 83: 701-707.
29. Grandone E, Corrao AM, Colaizzo D, et al. Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants. Prenat Diagn 2006; 26: 1-5. doi:10.1002/pd.1359.